132 related articles for article (PubMed ID: 8028628)
1. Interferon alfa-2a for chronic myeloid leukemia.
Kennedy BJ
N Engl J Med; 1994 Aug; 331(6):402. PubMed ID: 8028628
[No Abstract] [Full Text] [Related]
2. Evolving approaches with interferon alfa in chronic myelogenous leukemia.
Morra E; Alimena G; Lazzarino M; Liberati AM; Montefusco E; Bernasconi P; Mancini M; Donti E; Merante S; Caricchi P
Semin Hematol; 1993 Jul; 30(3 Suppl 3):26-7. PubMed ID: 8235701
[No Abstract] [Full Text] [Related]
3. Interferon alfa-2a for chronic myeloid leukemia.
Mehta J
N Engl J Med; 1994 Aug; 331(6):401; author reply 402. PubMed ID: 8068137
[No Abstract] [Full Text] [Related]
4. Interferon alfa-2a for chronic myeloid leukemia.
Atkins CD
N Engl J Med; 1994 Aug; 331(6):401-2. PubMed ID: 8028627
[No Abstract] [Full Text] [Related]
5. Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia.
; Tura S; Baccarani M; Zuffa E; Russo D; Fanin R; Zaccaria A; Fiacchini M
N Engl J Med; 1994 Mar; 330(12):820-5. PubMed ID: 8114834
[TBL] [Abstract][Full Text] [Related]
6. Low-dose interferon-alpha 2b combined with hydroxyurea versus hydroxyurea alone for chronic myelogenous leukemia.
Benelux CML Study Group
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S19-20. PubMed ID: 8769694
[No Abstract] [Full Text] [Related]
7. Alpha-2a-interferon administration and Fc gamma RIII expression on neutrophils from chronic myeloid leukemia.
Carulli G; Papineschi F; Azzarà A; Ambrogi F
Leuk Res; 1996 Jul; 20(7):627-8. PubMed ID: 8795698
[No Abstract] [Full Text] [Related]
8. Combined therapy interferon and chemotherapy in chronic myelogenous leukemia.
Guilhot F; Dreyfus B; Desmarest MC; Giraud C; Huret JL; Brizard A; Tanzer J
Nouv Rev Fr Hematol (1978); 1989; 31(2):171-3. PubMed ID: 2771633
[TBL] [Abstract][Full Text] [Related]
9. [Treatment with interferon alfa-2a in the chronic phase of Philadelphia-positive chronic myeloid leukemia].
Steegmann JL; Lavilla E; Somolinos N; Pérez-Sánchez M; Lamana M; Olmeda F; Cámara R; Arranz R; Ferro MT; Fernández-Rañada JM
Sangre (Barc); 1992 Oct; 37(5):375-81. PubMed ID: 1293778
[TBL] [Abstract][Full Text] [Related]
10. Interferon alpha-2a to control thrombocytosis in chronic myelogenous leukemia and essential thrombocythemia.
Jootar S
Asian Pac J Allergy Immunol; 1989 Dec; 7(2):103-5. PubMed ID: 2624663
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyurea versus interferon alfa-2b in chronic myelogenous leukaemia: preliminary results of an open French multicentre randomized study.
Broustet A; Reiffers J; Marit G; Fiere D; Jaubert J; Reynaud J; Pris J; Bernard P; Charrin C; Wen ZQ
Eur J Cancer; 1991; 27 Suppl 4():S18-21. PubMed ID: 1799467
[TBL] [Abstract][Full Text] [Related]
12. Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia.
Heimpel H; Allan NC; Baccarani M; Guilhot F; Hehlmann R; Horowitz M; Kluin-Nelemans J; Schaefer U; Storb R; Thaler J
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S39. PubMed ID: 8769699
[No Abstract] [Full Text] [Related]
13. [Interferon-alpha in the treatment of chronic myeloid leukemia].
Guilhot F
Rev Prat; 1999 Mar; 49(5):464-6. PubMed ID: 10358394
[No Abstract] [Full Text] [Related]
14. Treatment choices in chronic myelogenous leukemia.
Ready N; Freeman NJ; Carvalho A
Hosp Pract (Off Ed); 1992 Sep; 27(9A):95-8, 101. PubMed ID: 1522171
[No Abstract] [Full Text] [Related]
15. Interferon-alpha 2a therapy in CML: disappearance of BCR/ABL transcript in a case of long-lasting continuous cytogenetic conversion.
Pardini S; Addis M; Dore F; Bonfigli S; Nieddu RM; Galanello R; Longinotti M; Pau MG
Haematologica; 1994; 79(6):540-1. PubMed ID: 7896213
[TBL] [Abstract][Full Text] [Related]
16. [Mobilization of Ph-negative hematopoietic stem cells using rhG-CSF in patients with chronic myeloid leukemia treated with interferon-alfa. Experience of the Clinic Hospital of Barcelona].
Carreras E
Sangre (Barc); 1997 Apr; 42 Suppl 1():24-6. PubMed ID: 9381296
[No Abstract] [Full Text] [Related]
17. [The assessment of therapeutic success in chronic myeloid leukemia].
Griesshammer M; Hehlmann R; Heimpel H
Dtsch Med Wochenschr; 1995 Apr; 120(17):620-5. PubMed ID: 7537652
[No Abstract] [Full Text] [Related]
18. Diagnostic and therapeutic technology assessment. Alpha-interferon and chronic myelogenous leukemia.
JAMA; 1990 Oct 24-31; 264(16):2137-40. PubMed ID: 2214085
[No Abstract] [Full Text] [Related]
19. [Experience with the use of reaferon (alfa 2-interferon) for treating patients with chronic myeloleukemia].
Abdulkadyrov KM; Moiseev SI; Shcherbakova EG; Balashova VA; Glazanova TV; Rukavitsyn OA; Martynkevich IS; Gritsaev SV; Blinov MN
Ter Arkh; 1995; 67(6):59-63. PubMed ID: 7667786
[TBL] [Abstract][Full Text] [Related]
20. [Chronic myeloid leukemia--latest aspects and practical progress in recent years].
Griesshammer M; Heimpel H
Med Klin (Munich); 1995 Sep; 90(9):527-31. PubMed ID: 7476731
[No Abstract] [Full Text] [Related]
[Next] [New Search]
